These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11893233)

  • 21. Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.
    Resnick MI; Roehrborn CG
    Prostate Cancer Prostatic Dis; 2007; 10(2):155-9. PubMed ID: 17211442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.
    Andersen M; Dahlstrand C; Høye K
    Eur Urol; 2000 Oct; 38(4):400-9. PubMed ID: 11025377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical uroselectivity of alfuzosin in the treatment of benign prostatic hyperplasia.
    Kirby RS
    Eur Urol; 1998; 33 Suppl 2():19-27. PubMed ID: 9556192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Roehrborn CG; Gittelman M; Kim D; Forrest J; Jacobs S
    Urology; 2003 Nov; 62(5):888-93. PubMed ID: 14624914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
    Elhilali M; Emberton M; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Alcaraz A; Vallancien G;
    BJU Int; 2006 Mar; 97(3):513-9. PubMed ID: 16469018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia.
    Kuritzky L; Rosenberg MT; Sadovsky R
    Int J Clin Pract; 2006 Mar; 60(3):351-8. PubMed ID: 16494652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.
    Buzelin JM; Fonteyne E; Kontturi M; Witjes WP; Khan A
    Br J Urol; 1997 Oct; 80(4):597-605. PubMed ID: 9352699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM; Klarskov P
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia.
    Wilde MI; McTavish D
    Drugs; 1996 Dec; 52(6):883-98. PubMed ID: 8957159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.
    Roehrborn CG; Rosen RC
    Clin Interv Aging; 2008; 3(3):511-24. PubMed ID: 18982921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alfuzosin for the management of benign prostate hyperplasia.
    Weiner DM; Lowe FC
    Expert Opin Pharmacother; 2003 Nov; 4(11):2057-63. PubMed ID: 14596659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Djavan B; Marberger M
    Eur Urol; 1999; 36(1):1-13. PubMed ID: 10364649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of sustained-release alfuzosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia in 3,095 Spanish patients evaluated during general practice.
    Sánchez-Chapado M; Guil M; Alfaro V; Badiella L; Fernández-Hernando N
    Eur Urol; 2000 Apr; 37(4):421-7. PubMed ID: 10765072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.
    Debruyne FM; Jardin A; Colloi D; Resel L; Witjes WP; Delauche-Cavallier MC; McCarthy C; Geffriaud-Ricouard C
    Eur Urol; 1998 Sep; 34(3):169-75. PubMed ID: 9732187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin.
    Saad F; Nickel JC; Valiquette L; Casey R; Kuzmarov I; Elhilali M;
    Can J Urol; 2005 Aug; 12(4):2745-54. PubMed ID: 16197598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of alfuzosin 10 mg once daily on quality of life in Tunisian patients with lower urinary symptoms suggestive of benign prostatic hyperplasia].
    Ben Rhouma S; H'sairi M; Adbi H; Binous MY; Nouira Y; Ben Raies N; Mosbah AT; Horchani A
    Tunis Med; 2015 Mar; 93(3):164-9. PubMed ID: 26367405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical uroselectivity of alfuzosin is not significantly affected by the age of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Sánchez-Chapado M; Guil M; Badiella LI; Fernández-Hernando N; Alfaro V
    BJU Int; 2000 Sep; 86(4):432-8. PubMed ID: 10971267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.
    Kirby RS; Andersen M; Gratzke P; Dahlstrand C; Høye K
    BJU Int; 2001 Feb; 87(3):192-200. PubMed ID: 11167641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Höfner K; Claes H; De Reijke TM; Folkestad B; Speakman MJ
    Eur Urol; 1999 Oct; 36(4):335-41. PubMed ID: 10473995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.